These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32149543)

  • 1. An overview of cannabis based treatment in Crohn's disease.
    Naftali T
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):253-257. PubMed ID: 32149543
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
    Hasenoehrl C; Storr M; Schicho R
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
    Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.
    Naftali T; Bar-Lev Schleider L; Dotan I; Lansky EP; Sklerovsky Benjaminov F; Konikoff FM
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1276-1280.e1. PubMed ID: 23648372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Inflamm Bowel Dis; 2020 Mar; 26(4):502-509. PubMed ID: 31613959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
    Volz MS; Siegmund B; Häuser W
    Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis, a potential treatment option in pediatric IBD? Still a long way to go.
    Halbmeijer N; Groeneweg M; De Ridder L
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):355-361. PubMed ID: 30767696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis for inflammatory bowel disease.
    Naftali T; Mechulam R; Lev LB; Konikoff FM
    Dig Dis; 2014; 32(4):468-74. PubMed ID: 24969296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.
    Naftali T; Mechulam R; Marii A; Gabay G; Stein A; Bronshtain M; Laish I; Benjaminov F; Konikoff FM
    Dig Dis Sci; 2017 Jun; 62(6):1615-1620. PubMed ID: 28349233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical marijuana for inflammatory bowel disease: the highs and lows.
    Wynne J; Kozuch P
    Scand J Gastroenterol; 2022 Feb; 57(2):197-205. PubMed ID: 34919496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis Consumption.
    Tartakover Matalon S; Azar S; Meiri D; Hadar R; Nemirovski A; Abu Jabal N; Konikoff FM; Drucker L; Tam J; Naftali T
    Front Endocrinol (Lausanne); 2021; 12():685289. PubMed ID: 34531823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, Perception, and Use of Cannabis Therapy in Patients with Inflammatory Bowel Disease.
    Muñiz-Camacho LA; Negrón-Quintana FI; Ramos-Burgos LA; Cruz-Cruz JJ; Torres EA
    P R Health Sci J; 2021 Sep; 40(3):110-114. PubMed ID: 34792923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis finds its way into treatment of Crohn's disease.
    Schicho R; Storr M
    Pharmacology; 2014; 93(1-2):1-3. PubMed ID: 24356243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases.
    Kienzl M; Storr M; Schicho R
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00120. PubMed ID: 31899693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial.
    Naftali T; Bar-Lev Schleider L; Almog S; Meiri D; Konikoff FM
    J Crohns Colitis; 2021 Nov; 15(11):1799-1806. PubMed ID: 33858011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023.
    Lewis M; Baroutian S; Hanning SM
    Curr Pain Headache Rep; 2024 Mar; 28(3):109-118. PubMed ID: 38095748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic Use of Cannabis in Inflammatory Bowel Disease.
    Ahmed W; Katz S
    Gastroenterol Hepatol (N Y); 2016 Nov; 12(11):668-679. PubMed ID: 28035196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.